Correlation Between Apexigen and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Apexigen and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apexigen and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apexigen and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Apexigen and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apexigen with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apexigen and Navidea Biopharmaceutica.
Diversification Opportunities for Apexigen and Navidea Biopharmaceutica
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Apexigen and Navidea is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Apexigen and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Apexigen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apexigen are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Apexigen i.e., Apexigen and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between Apexigen and Navidea Biopharmaceutica
If you would invest 9.96 in Navidea Biopharmaceuticals on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Navidea Biopharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Apexigen vs. Navidea Biopharmaceuticals
Performance |
Timeline |
Apexigen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Apexigen and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apexigen and Navidea Biopharmaceutica
The main advantage of trading using opposite Apexigen and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apexigen position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.Apexigen vs. Leap Therapeutics | Apexigen vs. Zura Bio Limited | Apexigen vs. X4 Pharmaceuticals | Apexigen vs. Phio Pharmaceuticals Corp |
Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |